Wesolowski R, Rugo HS, Specht JM, Han H, et al. Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer. Clin Cancer Res 2025 Jul 25. doi: 10.1158/1078-0432.CCR-25-0992.
PMID: 40711480